| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.081 | 0.2 |